Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise

E-ISSN： 1875-6190|7|4|331-336

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.7, Iss.4, 2009-12, pp. : 331-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonin-Norepinephrine Reuptake Inhibitor Antidepressants and the Risk of Falls in Older People: Case-Control and Case-Series Analysis of a Large UK Primary Care Database

By Gribbin Jonathan

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 895-902

Adis International

Access to resources Recommend Favorite

Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters

By Beque J.-C. Lavoie N. de Montigny C. Debonnel G.

European Journal of Pharmacology, Vol. 349, Iss. 1, 1998-05 ,pp. : 129-132

Elsevier

Access to resources Recommend Favorite

Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin–norepinephrine reuptake inhibitor

By Nichols Alice I Tourian Karen A Tse Susanna Y Paul Jeffrey

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1565-1574

Informa Healthcare

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors in Pregnancy

Current Medicinal Chemistry, Vol. 19, Iss. 27, 2012-09 ,pp. : 4554-4561

Bentham Science Publishers

Access to resources Recommend Favorite

Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon

By Wolff M.C. Leander J.D.

European Journal of Pharmacology, Vol. 345, Iss. 1, 1998-03 ,pp. : 35-39

Elsevier

Access to resources Recommend Favorite